• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

POZN:US

8.7200 USD 0.2000 2.24%

As of 12:36:16 ET on 07/10/2014.

Snapshot for POZEN Inc (POZN)

Open: 8.7300 Day's Range: 8.6100 - 8.8200 Volume: 82,179
Previous Close: 8.9200 52wk Range: 4.0278 - 9.7300 1-Yr Rtn: +92.45%

Stock Chart for POZN

No chart data available.
  • POZN:US 8.7200
  • 1D
  • 1M
  • 1Y
8.9200
Interactive POZN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for POZN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 15.3793
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2700
Est. EPS (USD) (12/2014) 0.5800
Est. PEG Ratio -
Market Cap (M USD) 275.23
Shares Outstanding (M) 30.85
30 Day Average Volume 314,188
Price/Book (mrq) 12.3433
Price/Sale (ttm) 16.2638
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.7500
Dividend Ex-Date 12/31/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for POZN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for POZN

POZEN Inc. is a pharmaceutical company that develops therapeutics for diseases with unmet medical needs. The Company's product candidates include migraine treatments as well as is exploring the development of product candidates in other pain-related therapeutic areas.

John R PlachetkaChairman/President/CEOJohn G FortChief Medical Officer
Tomas S BocanegraExec VP:Product DevelopmentDennis L McNamaraSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for POZN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil